Pharmacological inhibition of EZH2 combined with DNA‑damaging agents interferes with the DNA damage response in MM cells-Reference-Cited by-同舟云学术

Pharmacological inhibition of EZH2 combined with DNA‑damaging agents interferes with the DNA damage response in MM cells

Published:2019-03-21 Issue: Volume: Page:
ISSN:1791-2997
Container-title:Molecular Medicine Reports
language:
Short-container-title:Mol Med Report

Author:

Xu Li¹,Tang Hailong¹,Wang Kai²,Zheng Yanhua¹,Feng Juan¹,Dong Hongjuan¹,Jin Yulong¹,Cao Chun¹,Chen Xiequn¹,Gao Guangxun¹

Affiliation:

1. Department of Hematology, People's Liberation Army Center of Hematologic Disorders, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi 710032, P.R. China

2. Department of Gastroenterology, The 16th Hospital of the People's Liberation Army of China, Xinjiang 836599, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,Genetics,Molecular Biology,Molecular Medicine,Biochemistry

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SAM-Competitive EZH2-Inhibitors Induce Platinum Resistance by EZH2-Independent Induction of ABC-Transporters;Cancers;2023-06-03

2. High-throughput approaches to uncover synergistic drug combinations in leukemia;SLAS Discovery;2023-06

3. Combined inhibition of EZH2 and ATM is synthetic lethal in BRCA1-deficient breast cancer;Breast Cancer Research;2022-06-17

4. Characterization of a castrate-resistant prostate cancer xenograft derived from a patient of West African ancestry;Prostate Cancer and Prostatic Diseases;2021-10-13

5. One Omics Approach Does Not Rule Them All: The Metabolome and the Epigenome Join Forces in Haematological Malignancies;Epigenomes;2021-10-08